 | • レポートコード：QFJ1-4733 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ポリピル製品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（心血管疾患、糖尿病、抗感染症、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ポリピル製品の市場動向 ・企業の競争状況、市場シェア ・ポリピル製品の種類別市場規模と予測2016-2027（心血管疾患、糖尿病、抗感染症、その他） ・ポリピル製品の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・ポリピル製品の北米市場規模2016-2027（アメリカ、カナダ） ・ポリピル製品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ポリピル製品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ポリピル製品の中南米市場規模2016-2027（メキシコ、ブラジル） ・ポリピル製品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer, Inc.、AstraZeneca、Merck & Co、Janssen Pharmaceuticals, Inc. (Johnson & Johnson)、Dr. Reddy’s Laboratories Ltd.、Cipla, Inc.、Cadila Pharmaceuticals、Grupo Ferrer International、Takeda Pharmaceutical Company Limited、Gebro Pharma GmbH、Gilead Sciences, Inc.） ・結論 |
Polypill is a fixed dose drug combination used in the treatment of various chronic diseases. This combination pharmacotherapy offers the potential to decrease the incidence and prevalence of cardiovascular and other diseases. Polypill improves patient compliance, thereby increasing the adoption of these products. This is likely to boost the growth of the global polypill products market. Moreover, ease of dosage understanding for elderly patients and increase in usage of polypill products are the major advantages offered by polypill products over other formulations. Combination therapy is more effective than a single substance with an acceptable safety profile.
Market Analysis and Insights: Global Polypill Products Market
The global Polypill Products market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Polypill Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Polypill Products market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Polypill Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Polypill Products market.
Global Polypill Products Scope and Market Size
Polypill Products market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polypill Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cardiovascular Diseases
Diabetes Mellitus
Anti-infective
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer, Inc.
AstraZeneca
Merck & Co
Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
Dr. Reddy’s Laboratories Ltd.
Cipla, Inc.
Cadila Pharmaceuticals
Grupo Ferrer International
Takeda Pharmaceutical Company Limited
Gebro Pharma GmbH
Gilead Sciences, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Polypill Products Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cardiovascular Diseases
1.2.3 Diabetes Mellitus
1.2.4 Anti-infective
1.2.5 Others
1.3 Market by Application
1.3.1 Global Polypill Products Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Polypill Products Market Perspective (2016-2027)
2.2 Polypill Products Growth Trends by Regions
2.2.1 Polypill Products Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Polypill Products Historic Market Share by Regions (2016-2021)
2.2.3 Polypill Products Forecasted Market Size by Regions (2022-2027)
2.3 Polypill Products Industry Dynamic
2.3.1 Polypill Products Market Trends
2.3.2 Polypill Products Market Drivers
2.3.3 Polypill Products Market Challenges
2.3.4 Polypill Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Polypill Products Players by Revenue
3.1.1 Global Top Polypill Products Players by Revenue (2016-2021)
3.1.2 Global Polypill Products Revenue Market Share by Players (2016-2021)
3.2 Global Polypill Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Polypill Products Revenue
3.4 Global Polypill Products Market Concentration Ratio
3.4.1 Global Polypill Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Polypill Products Revenue in 2020
3.5 Polypill Products Key Players Head office and Area Served
3.6 Key Players Polypill Products Product Solution and Service
3.7 Date of Enter into Polypill Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Polypill Products Breakdown Data by Type
4.1 Global Polypill Products Historic Market Size by Type (2016-2021)
4.2 Global Polypill Products Forecasted Market Size by Type (2022-2027)
5 Polypill Products Breakdown Data by Application
5.1 Global Polypill Products Historic Market Size by Application (2016-2021)
5.2 Global Polypill Products Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Polypill Products Market Size (2016-2027)
6.2 North America Polypill Products Market Size by Type
6.2.1 North America Polypill Products Market Size by Type (2016-2021)
6.2.2 North America Polypill Products Market Size by Type (2022-2027)
6.2.3 North America Polypill Products Market Size by Type (2016-2027)
6.3 North America Polypill Products Market Size by Application
6.3.1 North America Polypill Products Market Size by Application (2016-2021)
6.3.2 North America Polypill Products Market Size by Application (2022-2027)
6.3.3 North America Polypill Products Market Size by Application (2016-2027)
6.4 North America Polypill Products Market Size by Country
6.4.1 North America Polypill Products Market Size by Country (2016-2021)
6.4.2 North America Polypill Products Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Polypill Products Market Size (2016-2027)
7.2 Europe Polypill Products Market Size by Type
7.2.1 Europe Polypill Products Market Size by Type (2016-2021)
7.2.2 Europe Polypill Products Market Size by Type (2022-2027)
7.2.3 Europe Polypill Products Market Size by Type (2016-2027)
7.3 Europe Polypill Products Market Size by Application
7.3.1 Europe Polypill Products Market Size by Application (2016-2021)
7.3.2 Europe Polypill Products Market Size by Application (2022-2027)
7.3.3 Europe Polypill Products Market Size by Application (2016-2027)
7.4 Europe Polypill Products Market Size by Country
7.4.1 Europe Polypill Products Market Size by Country (2016-2021)
7.4.2 Europe Polypill Products Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Polypill Products Market Size (2016-2027)
8.2 Asia-Pacific Polypill Products Market Size by Type
8.2.1 Asia-Pacific Polypill Products Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Polypill Products Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Polypill Products Market Size by Type (2016-2027)
8.3 Asia-Pacific Polypill Products Market Size by Application
8.3.1 Asia-Pacific Polypill Products Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Polypill Products Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Polypill Products Market Size by Application (2016-2027)
8.4 Asia-Pacific Polypill Products Market Size by Region
8.4.1 Asia-Pacific Polypill Products Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Polypill Products Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Polypill Products Market Size (2016-2027)
9.2 Latin America Polypill Products Market Size by Type
9.2.1 Latin America Polypill Products Market Size by Type (2016-2021)
9.2.2 Latin America Polypill Products Market Size by Type (2022-2027)
9.2.3 Latin America Polypill Products Market Size by Type (2016-2027)
9.3 Latin America Polypill Products Market Size by Application
9.3.1 Latin America Polypill Products Market Size by Application (2016-2021)
9.3.2 Latin America Polypill Products Market Size by Application (2022-2027)
9.3.3 Latin America Polypill Products Market Size by Application (2016-2027)
9.4 Latin America Polypill Products Market Size by Country
9.4.1 Latin America Polypill Products Market Size by Country (2016-2021)
9.4.2 Latin America Polypill Products Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Polypill Products Market Size (2016-2027)
10.2 Middle East & Africa Polypill Products Market Size by Type
10.2.1 Middle East & Africa Polypill Products Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Polypill Products Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Polypill Products Market Size by Type (2016-2027)
10.3 Middle East & Africa Polypill Products Market Size by Application
10.3.1 Middle East & Africa Polypill Products Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Polypill Products Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Polypill Products Market Size by Application (2016-2027)
10.4 Middle East & Africa Polypill Products Market Size by Country
10.4.1 Middle East & Africa Polypill Products Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Polypill Products Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Details
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Polypill Products Introduction
11.1.4 Pfizer, Inc. Revenue in Polypill Products Business (2016-2021)
11.1.5 Pfizer, Inc. Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Polypill Products Introduction
11.2.4 AstraZeneca Revenue in Polypill Products Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Merck & Co
11.3.1 Merck & Co Company Details
11.3.2 Merck & Co Business Overview
11.3.3 Merck & Co Polypill Products Introduction
11.3.4 Merck & Co Revenue in Polypill Products Business (2016-2021)
11.3.5 Merck & Co Recent Development
11.4 Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
11.4.1 Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Company Details
11.4.2 Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Business Overview
11.4.3 Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Polypill Products Introduction
11.4.4 Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Revenue in Polypill Products Business (2016-2021)
11.4.5 Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Recent Development
11.5 Dr. Reddy’s Laboratories Ltd.
11.5.1 Dr. Reddy’s Laboratories Ltd. Company Details
11.5.2 Dr. Reddy’s Laboratories Ltd. Business Overview
11.5.3 Dr. Reddy’s Laboratories Ltd. Polypill Products Introduction
11.5.4 Dr. Reddy’s Laboratories Ltd. Revenue in Polypill Products Business (2016-2021)
11.5.5 Dr. Reddy’s Laboratories Ltd. Recent Development
11.6 Cipla, Inc.
11.6.1 Cipla, Inc. Company Details
11.6.2 Cipla, Inc. Business Overview
11.6.3 Cipla, Inc. Polypill Products Introduction
11.6.4 Cipla, Inc. Revenue in Polypill Products Business (2016-2021)
11.6.5 Cipla, Inc. Recent Development
11.7 Cadila Pharmaceuticals
11.7.1 Cadila Pharmaceuticals Company Details
11.7.2 Cadila Pharmaceuticals Business Overview
11.7.3 Cadila Pharmaceuticals Polypill Products Introduction
11.7.4 Cadila Pharmaceuticals Revenue in Polypill Products Business (2016-2021)
11.7.5 Cadila Pharmaceuticals Recent Development
11.8 Grupo Ferrer International
11.8.1 Grupo Ferrer International Company Details
11.8.2 Grupo Ferrer International Business Overview
11.8.3 Grupo Ferrer International Polypill Products Introduction
11.8.4 Grupo Ferrer International Revenue in Polypill Products Business (2016-2021)
11.8.5 Grupo Ferrer International Recent Development
11.9 Takeda Pharmaceutical Company Limited
11.9.1 Takeda Pharmaceutical Company Limited Company Details
11.9.2 Takeda Pharmaceutical Company Limited Business Overview
11.9.3 Takeda Pharmaceutical Company Limited Polypill Products Introduction
11.9.4 Takeda Pharmaceutical Company Limited Revenue in Polypill Products Business (2016-2021)
11.9.5 Takeda Pharmaceutical Company Limited Recent Development
11.10 Gebro Pharma GmbH
11.10.1 Gebro Pharma GmbH Company Details
11.10.2 Gebro Pharma GmbH Business Overview
11.10.3 Gebro Pharma GmbH Polypill Products Introduction
11.10.4 Gebro Pharma GmbH Revenue in Polypill Products Business (2016-2021)
11.10.5 Gebro Pharma GmbH Recent Development
11.11 Gilead Sciences, Inc.
11.11.1 Gilead Sciences, Inc. Company Details
11.11.2 Gilead Sciences, Inc. Business Overview
11.11.3 Gilead Sciences, Inc. Polypill Products Introduction
11.11.4 Gilead Sciences, Inc. Revenue in Polypill Products Business (2016-2021)
11.11.5 Gilead Sciences, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Polypill Products Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cardiovascular Diseases
Table 3. Key Players of Diabetes Mellitus
Table 4. Key Players of Anti-infective
Table 5. Key Players of Others
Table 6. Global Polypill Products Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Polypill Products Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Polypill Products Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Polypill Products Market Share by Regions (2016-2021)
Table 10. Global Polypill Products Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Polypill Products Market Share by Regions (2022-2027)
Table 12. Polypill Products Market Trends
Table 13. Polypill Products Market Drivers
Table 14. Polypill Products Market Challenges
Table 15. Polypill Products Market Restraints
Table 16. Global Polypill Products Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Polypill Products Market Share by Players (2016-2021)
Table 18. Global Top Polypill Products Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polypill Products as of 2020)
Table 19. Ranking of Global Top Polypill Products Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Polypill Products Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Polypill Products Product Solution and Service
Table 23. Date of Enter into Polypill Products Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Polypill Products Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Polypill Products Revenue Market Share by Type (2016-2021)
Table 27. Global Polypill Products Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Polypill Products Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Polypill Products Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Polypill Products Revenue Market Share by Application (2016-2021)
Table 31. Global Polypill Products Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Polypill Products Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Polypill Products Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Polypill Products Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Polypill Products Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Polypill Products Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Polypill Products Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Polypill Products Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Polypill Products Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Polypill Products Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Polypill Products Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Polypill Products Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Polypill Products Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Polypill Products Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Polypill Products Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Polypill Products Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Polypill Products Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Polypill Products Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Polypill Products Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Polypill Products Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Polypill Products Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Polypill Products Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Polypill Products Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Polypill Products Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Polypill Products Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Polypill Products Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Polypill Products Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Polypill Products Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Polypill Products Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Polypill Products Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Polypill Products Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Polypill Products Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer, Inc. Company Details
Table 64. Pfizer, Inc. Business Overview
Table 65. Pfizer, Inc. Polypill Products Product
Table 66. Pfizer, Inc. Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 67. Pfizer, Inc. Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Polypill Products Product
Table 71. AstraZeneca Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Merck & Co Company Details
Table 74. Merck & Co Business Overview
Table 75. Merck & Co Polypill Products Product
Table 76. Merck & Co Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 77. Merck & Co Recent Development
Table 78. Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Company Details
Table 79. Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Business Overview
Table 80. Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Polypill Products Product
Table 81. Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 82. Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Recent Development
Table 83. Dr. Reddy’s Laboratories Ltd. Company Details
Table 84. Dr. Reddy’s Laboratories Ltd. Business Overview
Table 85. Dr. Reddy’s Laboratories Ltd. Polypill Products Product
Table 86. Dr. Reddy’s Laboratories Ltd. Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 87. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 88. Cipla, Inc. Company Details
Table 89. Cipla, Inc. Business Overview
Table 90. Cipla, Inc. Polypill Products Product
Table 91. Cipla, Inc. Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 92. Cipla, Inc. Recent Development
Table 93. Cadila Pharmaceuticals Company Details
Table 94. Cadila Pharmaceuticals Business Overview
Table 95. Cadila Pharmaceuticals Polypill Products Product
Table 96. Cadila Pharmaceuticals Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 97. Cadila Pharmaceuticals Recent Development
Table 98. Grupo Ferrer International Company Details
Table 99. Grupo Ferrer International Business Overview
Table 100. Grupo Ferrer International Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 101. Grupo Ferrer International Recent Development
Table 102. Takeda Pharmaceutical Company Limited Company Details
Table 103. Takeda Pharmaceutical Company Limited Business Overview
Table 104. Takeda Pharmaceutical Company Limited Polypill Products Product
Table 105. Takeda Pharmaceutical Company Limited Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 106. Takeda Pharmaceutical Company Limited Recent Development
Table 107. Gebro Pharma GmbH Company Details
Table 108. Gebro Pharma GmbH Business Overview
Table 109. Gebro Pharma GmbH Polypill Products Product
Table 110. Gebro Pharma GmbH Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 111. Gebro Pharma GmbH Recent Development
Table 112. Gilead Sciences, Inc. Company Details
Table 113. Gilead Sciences, Inc. Business Overview
Table 114. Gilead Sciences, Inc. Polypill Products Product
Table 115. Gilead Sciences, Inc. Revenue in Polypill Products Business (2016-2021) & (US$ Million)
Table 116. Gilead Sciences, Inc. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Polypill Products Market Share by Type: 2020 VS 2027
Figure 2. Cardiovascular Diseases Features
Figure 3. Diabetes Mellitus Features
Figure 4. Anti-infective Features
Figure 5. Others Features
Figure 6. Global Polypill Products Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Polypill Products Report Years Considered
Figure 11. Global Polypill Products Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Polypill Products Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Polypill Products Market Share by Regions: 2020 VS 2027
Figure 14. Global Polypill Products Market Share by Regions (2022-2027)
Figure 15. Global Polypill Products Market Share by Players in 2020
Figure 16. Global Top Polypill Products Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polypill Products as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Polypill Products Revenue in 2020
Figure 18. Global Polypill Products Revenue Market Share by Type (2016-2021)
Figure 19. Global Polypill Products Revenue Market Share by Type (2022-2027)
Figure 20. North America Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Polypill Products Market Share by Type (2016-2027)
Figure 22. North America Polypill Products Market Share by Application (2016-2027)
Figure 23. North America Polypill Products Market Share by Country (2016-2027)
Figure 24. United States Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Polypill Products Market Share by Type (2016-2027)
Figure 28. Europe Polypill Products Market Share by Application (2016-2027)
Figure 29. Europe Polypill Products Market Share by Country (2016-2027)
Figure 30. Germany Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Polypill Products Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Polypill Products Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Polypill Products Market Share by Region (2016-2027)
Figure 40. China Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Polypill Products Market Share by Type (2016-2027)
Figure 48. Latin America Polypill Products Market Share by Application (2016-2027)
Figure 49. Latin America Polypill Products Market Share by Country (2016-2027)
Figure 50. Mexico Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Polypill Products Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Polypill Products Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Polypill Products Market Share by Country (2016-2027)
Figure 56. Turkey Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Polypill Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer, Inc. Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 61. Merck & Co Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 62. Janssen Pharmaceuticals, Inc. (Johnson & Johnson) Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 63. Dr. Reddy’s Laboratories Ltd. Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 64. Cipla, Inc. Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 65. Cadila Pharmaceuticals Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 66. Grupo Ferrer International Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 67. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 68. Gebro Pharma GmbH Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 69. Gilead Sciences, Inc. Revenue Growth Rate in Polypill Products Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…- 世界の体部白癬治療薬市場規模・現状・予測（2021年-2027年） Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea. Market Analysis and Insights: Global Tinea Corporis Drugs Market The gl…
- 世界のスイッチOTC医薬品市場規模・現状・予測（2021年-2027年） While many areas of the pharmaceutical industry will suffer from current economic conditions worldwide, sales of over-the-counter drugs are widely anticipated to grow as consumers seek cheaper alternatives. Market Analysis and Insights: Global Rx to OTC Switches Market The global Rx to OTC Switches …
- 世界の抗感染症療法市場規模・現状・予測（2021年-2027年） Anti-Infective Therapy is the infusion of antibiotic, antiviral, or antifungal drugs which are used to treat infections that do not respond to oral medications. Market Analysis and Insights: Global Anti-Infective Therapy Market The global Anti-Infective Therapy market size is projected to reach US$ …
- 世界の吸入麻酔薬市場規模・現状・予測（2021年-2027年） Inhalational anaesthesia drugs, ether and halothane were more commonly used in the past, and sevoflurane, desflurane, and isoflurane are more commonly used. Inhaled anesthetics can enter the lungs through the patient's respiratory tract, diffuse into the capillaries, and then enter the body's circul…